Court Nixes Bid To Boot Lead Avandia Plaintiff

Law360 (November 29, 2007, 12:00 AM EST) -- A fight between institutional investors vying for the role of lead plaintiff in a shareholder lawsuit over GlaxoSmithKline’s troubled diabetes drug Avandia has ended in a victory for Avon Pension Fund, which will remain at the helm of the action.

In a ruling handed down Wednesday in the U.S. District Court for the Southern District of New York, Judge Louis L. Stanton rejected a challenge by a group of German investors, referred to collectively in court documents as the German Institutional Investor Group, to bump Avon...
To view the full article, register now.
Law360 Pro Say Podcast
Check out Law360's new podcast, Pro Say, which offers a weekly recap of both the biggest stories and hidden gems from the world of law.